Combination treatment improves response to immunotherapy for lung cancer, mouse study shows

Researchers at the Francis Crick Institute, in collaboration with Revolution Medicines, have tested a combination of treatments in mice with lung cancer and shown that these allow immunotherapies to target non-responsive tumors.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup